| Joshua C Gross, MD | |
|
2841 Lexington Ave, Ashland, KY 41101-3009 | |
| (606) 324-2451 | |
| (606) 324-7123 |
| Full Name | Joshua C Gross |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 10 Years |
| Location | 2841 Lexington Ave, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144649914 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tri-state Ophthalmology Associates Psc | 9931157179 | 5 |
News Archive
Researchers from Case Western Reserve University in Cleveland have discovered that populating the gastrointestinal (GI) tracts of mice with Bacteroides species producing a specific enzyme helps protect the good commensal bacteria from the harmful effects of antibiotics.
The parasite that causes deadly sleeping sickness has its own biological clock that makes it more vulnerable to medications during the afternoon, according to international research that may help improve treatments for one of Africa's most lethal diseases.
Inspired by the negative results in the recently published largest-scale analysis of the relation between population density and positions in geographic ranges and environmental niches, Drs Jorge Soberon and Andrew Townsend Peterson of the University of Kansas, USA, teamed up with Luis Osorio-Olvera, National University of Mexico, and identified several issues in the methodology used, able to turn the tables in the ongoing debate.
Sentry BioPharma Services announced today that The Centers for Disease Control & Prevention (CDC) selected Sentry to store and distribute influenza vaccine in support of its national strategic reserve. Sentry will warehouse and distribute vaccine from its cGMP, FDA-registered facility located in Indianapolis, Ind. Sentry's vast experience storing and transporting regulated, temperature-sensitive pharmaceutical products will ensure product integrity, supply chain security and fast, efficient distribution of the disease-preventing vaccines.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.
› Verified 8 days ago
| Entity Name | Tri-state Ophthalmology Associates Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245261833 PECOS PAC ID: 9931157179 Enrollment ID: O20050105000134 |
News Archive
Researchers from Case Western Reserve University in Cleveland have discovered that populating the gastrointestinal (GI) tracts of mice with Bacteroides species producing a specific enzyme helps protect the good commensal bacteria from the harmful effects of antibiotics.
The parasite that causes deadly sleeping sickness has its own biological clock that makes it more vulnerable to medications during the afternoon, according to international research that may help improve treatments for one of Africa's most lethal diseases.
Inspired by the negative results in the recently published largest-scale analysis of the relation between population density and positions in geographic ranges and environmental niches, Drs Jorge Soberon and Andrew Townsend Peterson of the University of Kansas, USA, teamed up with Luis Osorio-Olvera, National University of Mexico, and identified several issues in the methodology used, able to turn the tables in the ongoing debate.
Sentry BioPharma Services announced today that The Centers for Disease Control & Prevention (CDC) selected Sentry to store and distribute influenza vaccine in support of its national strategic reserve. Sentry will warehouse and distribute vaccine from its cGMP, FDA-registered facility located in Indianapolis, Ind. Sentry's vast experience storing and transporting regulated, temperature-sensitive pharmaceutical products will ensure product integrity, supply chain security and fast, efficient distribution of the disease-preventing vaccines.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua C Gross, MD 2841 Lexington Ave, Ashland, KY 41101-3009 Ph: (606) 324-2451 | Joshua C Gross, MD 2841 Lexington Ave, Ashland, KY 41101-3009 Ph: (606) 324-2451 |
News Archive
Researchers from Case Western Reserve University in Cleveland have discovered that populating the gastrointestinal (GI) tracts of mice with Bacteroides species producing a specific enzyme helps protect the good commensal bacteria from the harmful effects of antibiotics.
The parasite that causes deadly sleeping sickness has its own biological clock that makes it more vulnerable to medications during the afternoon, according to international research that may help improve treatments for one of Africa's most lethal diseases.
Inspired by the negative results in the recently published largest-scale analysis of the relation between population density and positions in geographic ranges and environmental niches, Drs Jorge Soberon and Andrew Townsend Peterson of the University of Kansas, USA, teamed up with Luis Osorio-Olvera, National University of Mexico, and identified several issues in the methodology used, able to turn the tables in the ongoing debate.
Sentry BioPharma Services announced today that The Centers for Disease Control & Prevention (CDC) selected Sentry to store and distribute influenza vaccine in support of its national strategic reserve. Sentry will warehouse and distribute vaccine from its cGMP, FDA-registered facility located in Indianapolis, Ind. Sentry's vast experience storing and transporting regulated, temperature-sensitive pharmaceutical products will ensure product integrity, supply chain security and fast, efficient distribution of the disease-preventing vaccines.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.
› Verified 8 days ago
Mary Martha Reams, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 350, Ashland, KY 41101 Phone: 606-408-4600 Fax: 606-408-4605 | |
Mr. Carter H Gussler, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lexington Ave, Ashland, KY 41101 Phone: 606-324-2451 Fax: 606-324-7123 | |
Mr. John C Gross, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lexington Ave, Ashland, KY 41101 Phone: 606-324-2451 Fax: 606-324-7123 | |
Cody A Williams, DO Ophthalmology Medicare: Medicare Enrolled Practice Location: 2841 Lexington Ave, Ashland, KY 41101 Phone: 606-324-2451 Fax: 606-324-7123 | |
Dr. Maurice J Oakley, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1901 Winchester Ave, Suite 102, Ashland, KY 41101 Phone: 606-329-2211 Fax: 606-324-9207 |